Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis for Palliative Care in Cancer
NCT06266611Phase 2Recruiting
- Sponsor
- University of Colorado Boulder
- Start
- Sep 2024
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in cancer pain, sleep disorder, anxiety disorder and 1 more (3 arms), sponsored by University of Colorado Boulder. Primary endpoints: Pain Interference at 8 weeks, Pain Intensity at 8 weeks and 5 more. Started Sep 2024; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
cancer painsleep disorderanxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06266611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06266611.